- Home
- ATSG vs CRGX Comparison
ATSG vs CRGX Comparison
Compare ATSG & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATSG
- CRGX
- Stock Information
- Founded
- ATSG 1980
- CRGX 2021
- Country
- ATSG United States
- CRGX United States
- Employees
- ATSG N/A
- CRGX N/A
- Industry
- ATSG Air Freight/Delivery Services
- CRGX
- Sector
- ATSG Consumer Discretionary
- CRGX
- Exchange
- ATSG Nasdaq
- CRGX Nasdaq
- Market Cap
- ATSG 1.1B
- CRGX 964.5M
- IPO Year
- ATSG N/A
- CRGX 2023
- Fundamental
- Price
- ATSG $22.02
- CRGX $16.00
- Analyst Decision
- ATSG Buy
- CRGX Strong Buy
- Analyst Count
- ATSG 5
- CRGX 7
- Target Price
- ATSG $20.60
- CRGX $30.33
- AVG Volume (30 Days)
- ATSG 1.8M
- CRGX 167.8K
- Earning Date
- ATSG 11-08-2024
- CRGX 11-12-2024
- Dividend Yield
- ATSG N/A
- CRGX N/A
- EPS Growth
- ATSG N/A
- CRGX N/A
- EPS
- ATSG N/A
- CRGX N/A
- Revenue
- ATSG $1,962,220,000.00
- CRGX N/A
- Revenue This Year
- ATSG N/A
- CRGX N/A
- Revenue Next Year
- ATSG $4.10
- CRGX N/A
- P/E Ratio
- ATSG N/A
- CRGX N/A
- Revenue Growth
- ATSG N/A
- CRGX N/A
- 52 Week Low
- ATSG $11.62
- CRGX $13.56
- 52 Week High
- ATSG $22.27
- CRGX $33.92
- Technical
- Relative Strength Index (RSI)
- ATSG 84.71
- CRGX 32.69
- Support Level
- ATSG $22.00
- CRGX $19.96
- Resistance Level
- ATSG $22.14
- CRGX $23.00
- Average True Range (ATR)
- ATSG 0.25
- CRGX 1.79
- MACD
- ATSG 0.18
- CRGX -0.58
- Stochastic Oscillator
- ATSG 95.31
- CRGX 7.04
About ATSG Air Transport Services Group Inc
Air Transport Services Group Inc along with its subsidiaries operates within the airfreight and logistics industry. It leases aircraft and provides airline operations, ground services, aircraft modification and maintenance, and other support services mainly to the cargo transportation and package delivery industries. The company has two reportable segments namely Cargo Aircraft Management and ACMI Services (Aircraft, Crew, Maintenance, and Insurance). It generates a majority of its revenue from the ACMI services segment.
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.